Next generation sequencing (NGS) technologies are generating a wealth of mutation information for common cancers. However, key challenges must be overcome to avoid common pitfalls and ensure only clinically significant mutations are reported. Learn how to avoid these pitfalls and provide clinicians with the most meaningful information for their patients.